Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-17-202488
Filing Date
2017-06-13
Accepted
2017-06-13 16:31:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d410578d8k.htm 425 20697
2 EX-99.1 d410578dex991.htm EX-99.1 14634
  Complete submission text file 0001193125-17-202488.txt   37173
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Filed by) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Subject) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 033-80623 | Film No.: 17909199
SIC: 2835 In Vitro & In Vivo Diagnostic Substances